1. Home
  2. UK vs PRFX Comparison

UK vs PRFX Comparison

Compare UK & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ucommune International Ltd

UK

Ucommune International Ltd

N/A

Current Price

$0.54

Market Cap

3.4M

ML Signal

N/A

Logo PainReform Ltd.

PRFX

PainReform Ltd.

N/A

Current Price

$2.59

Market Cap

2.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UK
PRFX
Founded
2015
2007
Country
China
Israel
Employees
127
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
2.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UK
PRFX
Price
$0.54
$2.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
85.7K
193.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.58
52 Week High
$1.21
$3.71

Technical Indicators

Market Signals
Indicator
UK
PRFX
Relative Strength Index (RSI) 48.48 52.84
Support Level N/A $1.28
Resistance Level $1.17 $3.65
Average True Range (ATR) 0.05 0.26
MACD 0.01 -0.13
Stochastic Oscillator 98.97 5.14

Price Performance

Historical Comparison
UK
PRFX

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: